- ICH GCP
- Registro de ensayos clínicos de la UE
Últimos ensayos
EudraCT Number: 2019-003676-39 | Sponsor Protocol Number: 109147 | Start Date: | ||||||
Sponsor Name: | ||||||||
Full Title: Effects of sodium lactate infusion in patients with glucose transporter 1 deficiency syndrome (GLUT1DS) | ||||||||
Medical condition: In glucose transporter 1 deficiency syndrome (GLUT1DS) cerebral glucose uptake from the systemic blood circulation is limited, because of deficient transport of glucose across the blood-brain barri... | ||||||||
|
||||||||
Population Age: Children, Under 18 | Gender: Male, Female | |||||||
Trial protocol: NL (Ongoing) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2006-006912-31 | Sponsor Protocol Number: AMV-12_12_2006 | Start Date: | ||||||
Sponsor Name: Universitätsklinikum Schleswig-Holstein | ||||||||
Full Title: Vereidung maschineller Beatmung bei sehr kleinen Frühgeborenen - Avoid mechanical ventilation (The AMV-Trial) | ||||||||
Medical condition: Respiratory distress syndrom of preterm infants (ICD 10: P22.0) | ||||||||
|
||||||||
Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | |||||||
Trial protocol: DE (Ongoing) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2020-000412-30 | Sponsor Protocol Number: LF111/401 | Start Date: | |||||||||||
Sponsor Name: Chemo Research S.L. | |||||||||||||
Full Title: A multicenter, open-label, controlled study to investigate the effect of either LF111 or Drospirenone chewable tablets on bone mineral density (BMD) in adolescent and adult women in comparison with... | |||||||||||||
Medical condition: Oral contraception | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Female | ||||||||||||
Trial protocol: CZ (Ongoing) PL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-000205-77 | Sponsor Protocol Number: KF5503-75 | Start Date: | |||||||||||
Sponsor Name: Grünenthal GmbH | |||||||||||||
Full Title: Open-label investigation of the pharmacokinetic profile, safety, tolerability, and efficacy of multiple administrations of tapentadol oral solution used for treatment of acute pain in children aged... | |||||||||||||
Medical condition: Moderate to severe acute pain | |||||||||||||
|
|||||||||||||
Population Age: Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-002046-16 | Sponsor Protocol Number: MARS_2020 | Start Date: | ||||||
Sponsor Name: Fakultní nemocnice Brno | ||||||||
Full Title: A Randomised, double-blinded, placebo-controlled, multicenter study of efficacy, safety and side effects of highly diluted atropine collyrium in slowing the progression of myopia (shortsightedness)... | ||||||||
Medical condition: Myopia in children | ||||||||
|
||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |||||||
Trial protocol: CZ (Ongoing) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2017-003643-38 | Sponsor Protocol Number: 17-HPNCL-01 | Start Date: | |||||||||||
Sponsor Name: Fondation Lenval - Hôpitaux Pédiatriques de Nice CHU-LENVAL | |||||||||||||
Full Title: INTRANASAL KETAMINE IN THE REDUCTION OF THE ISOLATED FRACTURES OF THE HIGHER MEMBER OF THE CHILD TO PEDIATRIC EMERGENCIES | |||||||||||||
Medical condition: a fracture isolated from the distal end of the closed upper limb, requiring a reduction | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-004207-52 | Sponsor Protocol Number: CQGE031C2202 | Start Date: | |||||||||||
Sponsor Name: Novartis Pharma AG | |||||||||||||
Full Title: A multicenter, randomized, double-blind, placebo-controlled phase 2b dose-finding study to investigate the efficacy and safety of ligelizumab (QGE031) in adolescent patients with Chronic Spontaneou... | |||||||||||||
Medical condition: Chronic Spontaneous Urticaria | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) ES (Completed) BE (Completed) HU (Completed) EE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-000791-26 | Sponsor Protocol Number: PHRI13-GF/LEVNEONAT-1 | Start Date: | |||||||||||
Sponsor Name: CHRU TOURS | |||||||||||||
Full Title: Lévétiracétam pour le traitement en première intention des convulsions du nouveau-né : étude de phase II | |||||||||||||
Medical condition: Nouveau-nés à terme présentant des convulsions dans les premières 72h de vie. Nés dans un contexte d'asphyxie périnatale qu'ils soient éligibles ou non à l'hypothermie thérapeutique. | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-007667-17 | Sponsor Protocol Number: FINNjA-DM | Start Date: | ||||||
Sponsor Name: Dekan des Fachbereichs Medizin der Johann Wolfgang Goethe-Universität Frankfurt/M. | ||||||||
Full Title: Doppelblinde, randomisierte Placebo-kontrollierte crossover-Studie zur Erfassung des Effektes einer DPP-IV-Hemmung auf die Zahl und Funktion von Progenitorzellen sowie die Endothelfunktion von Pati... | ||||||||
Medical condition: Patients with stable diabetes mellitus typ 2 and HbA1c between 7,0% and 10,0% | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: DE (Prematurely Ended) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2011-003743-22 | Sponsor Protocol Number: D9422C00001 | Start Date: | ||||||
Sponsor Name: AstraZeneca AB | ||||||||
Full Title: A Multicenter, Open label, Non-Comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive | ||||||||
Medical condition: Crohn's Disease | ||||||||
|
||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |||||||
Trial protocol: DE (Completed) IT (Completed) | ||||||||
Trial results: View results |